Stay updated on GLPG1690 in IPF Subjects: Clinical Trial
Sign up to get notified when there's something new on the GLPG1690 in IPF Subjects: Clinical Trial page.

Latest updates to the GLPG1690 in IPF Subjects: Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedAdded Revision: v3.4.2 to the site; removed the government funding lapse notice and Revision: v3.4.1 from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check14 days agoChange DetectedNotice: A lapse in government funding may affect the timeliness of updates and processing of transactions; check cc.nih.gov and opm.gov for current status. The page also records a system revision from v3.4.0 to v3.4.1.SummaryDifference0.2%

- Check21 days agoChange DetectedMinor non-substantive text and labeling updates: glossary visibility toggle, QC criteria labeling, No FEAR Act Data addition, and a revision tag updated to v3.4.0 (replacing v3.3.4).SummaryDifference0.1%

- Check28 days agoChange DetectedStatistical Analysis Plan and Study Protocol PDFs were removed from the Study Documents, along with related IPD-sharing entries. This reduces access to primary trial documentation and methodological details.SummaryDifference17%

- Check35 days agoChange DetectedThe page now shows Revision: v3.3.4, replacing Revision: v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check57 days agoChange DetectedA Locations section has been added listing multiple study sites across the United States and Pontevedra, Spain, and the HHS Vulnerability Disclosure link has been removed.SummaryDifference1%

Stay in the know with updates to GLPG1690 in IPF Subjects: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GLPG1690 in IPF Subjects: Clinical Trial page.